Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 467

1.

Neuroethical issues in cognitive enhancement: Modafinil as the example of a workplace drug?

Brühl AB, d'Angelo C, Sahakian BJ.

Brain Neurosci Adv. 2019 Feb 15;3:2398212818816018. doi: 10.1177/2398212818816018. eCollection 2019 Jan-Dec. Review.

2.

Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios.

Zhang L, Huang CC, Dai Y, Luo Q, Ji Y, Wang K, Deng S, Yu J, Xu M, Du X, Tang Y, Shen C, Feng J, Sahakian BJ, Lin CP, Li F.

Transl Psychiatry. 2020 Feb 12;10(1):63. doi: 10.1038/s41398-020-0747-4.

3.

Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios.

Zhang L, Huang CC, Dai Y, Luo Q, Ji Y, Wang K, Deng S, Yu J, Xu M, Du X, Tang Y, Shen C, Feng J, Sahakian BJ, Lin CP, Li F.

Transl Psychiatry. 2020 Jan 27;10(1):9. doi: 10.1038/s41398-020-0692-2. Erratum in: Transl Psychiatry. 2020 Feb 12;10(1):63.

4.

Probabilistic reversal learning under acute tryptophan depletion in healthy humans: a conventional analysis.

Kanen JW, Arntz FE, Yellowlees R, Cardinal RN, Price A, Christmas DM, Sahakian BJ, Apergis-Schoute AM, Robbins TW.

J Psychopharmacol. 2020 Feb 18:269881120907991. doi: 10.1177/0269881120907991. [Epub ahead of print]

PMID:
32066325
5.

Psychometric Properties and Validation of the EMOTICOM Test Battery in a Healthy Danish Population.

Dam VH, Thystrup CK, Jensen PS, Bland AR, Mortensen EL, Elliott R, Sahakian BJ, Knudsen GM, Frokjaer VG, Stenbæk DS.

Front Psychol. 2019 Dec 3;10:2660. doi: 10.3389/fpsyg.2019.02660. eCollection 2019.

6.

Are candidate neurocognitive endophenotypes of OCD present in paediatric patients? A systematic review.

Marzuki AA, Pereira de Souza AMFL, Sahakian BJ, Robbins TW.

Neurosci Biobehav Rev. 2020 Jan;108:617-645. doi: 10.1016/j.neubiorev.2019.12.010. Epub 2019 Dec 9. Review.

PMID:
31821834
7.

Inhibition-Related Cortical Hypoconnectivity as a Candidate Vulnerability Marker for Obsessive-Compulsive Disorder.

Hampshire A, Zadel A, Sandrone S, Soreq E, Fineberg N, Bullmore ET, Robbins TW, Sahakian BJ, Chamberlain SR.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Feb;5(2):222-230. doi: 10.1016/j.bpsc.2019.09.010. Epub 2019 Oct 16.

8.

Shared alterations in resting-state brain connectivity in adults with attention-deficit/hyperactivity disorder and their unaffected first-degree relatives.

Pironti VA, Vatansever D, Sahakian BJ.

Psychol Med. 2019 Nov 26:1-11. doi: 10.1017/S0033291719003374. [Epub ahead of print]

PMID:
31769365
9.

Acute anxiety and autonomic arousal induced by CO2 inhalation impairs prefrontal executive functions in healthy humans.

Savulich G, Hezemans FH, van Ghesel Grothe S, Dafflon J, Schulten N, Brühl AB, Sahakian BJ, Robbins TW.

Transl Psychiatry. 2019 Nov 12;9(1):296. doi: 10.1038/s41398-019-0634-z.

10.

A Touchscreen Motivation Assessment Evaluated in Huntington's Disease Patients and R6/1 Model Mice.

Heath CJ, O'Callaghan C, Mason SL, Phillips BU, Saksida LM, Robbins TW, Barker RA, Bussey TJ, Sahakian BJ.

Front Neurol. 2019 Aug 9;10:858. doi: 10.3389/fneur.2019.00858. eCollection 2019.

11.

Dopaminergic drug treatment remediates exaggerated cingulate prediction error responses in obsessive-compulsive disorder.

Murray GK, Knolle F, Ersche KD, Craig KJ, Abbott S, Shabbir SS, Fineberg NA, Suckling J, Sahakian BJ, Bullmore ET, Robbins TW.

Psychopharmacology (Berl). 2019 Aug;236(8):2325-2336. doi: 10.1007/s00213-019-05292-2. Epub 2019 Jun 14.

12.

Innovative methods for improving cognition, motivation and wellbeing in schizophrenia.

Sahakian BJ, Savulich G.

World Psychiatry. 2019 Jun;18(2):168-170. doi: 10.1002/wps.20649. No abstract available.

13.

Are neuropsychiatric symptoms modifiable risk factors for cognitive decline in Alzheimer's disease and vascular dementia?

Savulich G, O'Brien JT, Sahakian BJ.

Br J Psychiatry. 2019 Apr 30:1-3. doi: 10.1192/bjp.2019.98. [Epub ahead of print]

PMID:
31036096
14.

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.

Koychev I, Lawson J, Chessell T, Mackay C, Gunn R, Sahakian B, Rowe JB, Thomas AJ, Rochester L, Chan D, Tom B, Malhotra P, Ballard C, Chessell I, Ritchie CW, Raymont V, Leroi I, Lengyel I, Murray M, Thomas DL, Gallacher J, Lovestone S.

BMJ Open. 2019 Mar 23;9(3):e024498. doi: 10.1136/bmjopen-2018-024498.

15.

A Randomized Trial Directly Comparing Ventral Capsule and Anteromedial Subthalamic Nucleus Stimulation in Obsessive-Compulsive Disorder: Clinical and Imaging Evidence for Dissociable Effects.

Tyagi H, Apergis-Schoute AM, Akram H, Foltynie T, Limousin P, Drummond LM, Fineberg NA, Matthews K, Jahanshahi M, Robbins TW, Sahakian BJ, Zrinzo L, Hariz M, Joyce EM.

Biol Psychiatry. 2019 May 1;85(9):726-734. doi: 10.1016/j.biopsych.2019.01.017. Epub 2019 Jan 30.

16.

Improvements in Attention Following Cognitive Training With the Novel "Decoder" Game on an iPad.

Savulich G, Thorp E, Piercy T, Peterson KA, Pickard JD, Sahakian BJ.

Front Behav Neurosci. 2019 Jan 21;13:2. doi: 10.3389/fnbeh.2019.00002. eCollection 2019.

17.

Moral Emotions and Social Economic Games in Paranoia.

Savulich G, Jeanes H, Rossides N, Kaur S, Zacharia A, Robbins TW, Sahakian BJ.

Front Psychiatry. 2018 Nov 21;9:615. doi: 10.3389/fpsyt.2018.00615. eCollection 2018.

18.

Structural correlates of cognitive impairment in normal pressure hydrocephalus.

Peterson KA, Mole TB, Keong NCH, DeVito EE, Savulich G, Pickard JD, Sahakian BJ.

Acta Neurol Scand. 2019 Mar;139(3):305-312. doi: 10.1111/ane.13052. Epub 2018 Dec 3.

19.

Naltrexone differentially modulates the neural correlates of motor impulse control in abstinent alcohol-dependent and polysubstance-dependent individuals.

Nestor LJ, Paterson LM, Murphy A, McGonigle J, Orban C, Reed L, Taylor E, Flechais R, Smith D, Bullmore ET, Ersche KD, Suckling J, Elliott R, Deakin B, Rabiner I, Lingford Hughes A, Sahakian BJ, Robbins TW, Nutt DJ; ICCAM Consortium.

Eur J Neurosci. 2019 Aug;50(3):2311-2321. doi: 10.1111/ejn.14262. Epub 2018 Nov 26.

20.

Novel Smartphone Interventions Improve Cognitive Flexibility and Obsessive-Compulsive Disorder Symptoms in Individuals with Contamination Fears.

Jalal B, Brühl A, O'Callaghan C, Piercy T, Cardinal RN, Ramachandran VS, Sahakian BJ.

Sci Rep. 2018 Oct 23;8(1):14923. doi: 10.1038/s41598-018-33142-2.

21.

Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans.

Skandali N, Rowe JB, Voon V, Deakin JB, Cardinal RN, Cormack F, Passamonti L, Bevan-Jones WR, Regenthal R, Chamberlain SR, Robbins TW, Sahakian BJ.

Neuropsychopharmacology. 2018 Dec;43(13):2645-2651. doi: 10.1038/s41386-018-0229-z. Epub 2018 Sep 26.

22.

Haste or Speed? Alterations in the Impact of Incentive Cues on Task Performance in Remitted and Depressed Patients With Bipolar Disorder.

Chase HW, Fournier JC, Aslam H, Stiffler R, Almeida JR, Sahakian BJ, Phillips ML.

Front Psychiatry. 2018 Sep 3;9:396. doi: 10.3389/fpsyt.2018.00396. eCollection 2018.

23.

Neurocognitive testing in the emergency department: A potential assessment tool for mild traumatic brain injury.

Lunter CM, Carroll EL, Housden C, Outtrim J, Forsyth F, Rivera A, Maimaris C, Boyle A, Sahakian BJ, Menon DK, Newcombe VF.

Emerg Med Australas. 2019 Jun;31(3):355-361. doi: 10.1111/1742-6723.13163. Epub 2018 Sep 3.

PMID:
30175893
24.

Methylphenidate-mediated motor control network enhancement in patients with traumatic brain injury.

Dorer CL, Manktelow AE, Allanson J, Sahakian BJ, Pickard JD, Bateman A, Menon DK, Stamatakis EA.

Brain Inj. 2018;32(8):1040-1049. doi: 10.1080/02699052.2018.1469166. Epub 2018 May 8.

PMID:
29738277
25.

Personalised treatments for traumatic brain injury: cognitive, emotional and motivational targets.

Savulich G, Menon DK, Stamatakis EA, Pickard JD, Sahakian BJ.

Psychol Med. 2018 Jul;48(9):1397-1399. doi: 10.1017/S0033291718000892. Epub 2018 Apr 11. No abstract available.

PMID:
29636117
26.

Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.

Mc Ardle R, Morris R, Hickey A, Del Din S, Koychev I, Gunn RN, Lawson J, Zamboni G, Ridha B, Sahakian BJ, Rowe JB, Thomas A, Zetterberg H, MacKay C, Lovestone S, Rochesteron L; Deep and Frequent Phenotyping study team (.

J Alzheimers Dis. 2018;63(1):331-341. doi: 10.3233/JAD-171116. Erratum in: J Alzheimers Dis. 2018;63(4):1557.

PMID:
29614664
27.

Default Mode Network Engagement Beyond Self-Referential Internal Mentation.

Vatansever D, Manktelow A, Sahakian BJ, Menon DK, Stamatakis EA.

Brain Connect. 2018 May;8(4):245-253. doi: 10.1089/brain.2017.0489. Epub 2018 Apr 5.

28.

Impaired cognitive plasticity and goal-directed control in adolescent obsessive-compulsive disorder.

Gottwald J, de Wit S, Apergis-Schoute AM, Morein-Zamir S, Kaser M, Cormack F, Sule A, Limmer W, Morris AC, Robbins TW, Sahakian BJ.

Psychol Med. 2018 Aug;48(11):1900-1908. doi: 10.1017/S0033291717003464. Epub 2018 Jan 22.

29.

Hyperconnectivity of the ventromedial prefrontal cortex in obsessive-compulsive disorder.

Apergis-Schoute AM, Bijleveld B, Gillan CM, Fineberg NA, Sahakian BJ, Robbins TW.

Brain Neurosci Adv. 2018 Jan 1;2:1-10. doi: 10.1177/2398212818808710. Epub 2018 Nov 30.

30.

Spectral Diversity in Default Mode Network Connectivity Reflects Behavioral State.

Craig MM, Manktelow AE, Sahakian BJ, Menon DK, Stamatakis EA.

J Cogn Neurosci. 2018 Apr;30(4):526-539. doi: 10.1162/jocn_a_01213. Epub 2017 Dec 6.

PMID:
29211655
31.

Hypoactivation and Dysconnectivity of a Frontostriatal Circuit During Goal-Directed Planning as an Endophenotype for Obsessive-Compulsive Disorder.

Vaghi MM, Hampshire A, Fineberg NA, Kaser M, Brühl AB, Sahakian BJ, Chamberlain SR, Robbins TW.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Nov;2(8):655-663. doi: 10.1016/j.bpsc.2017.05.005.

32.

Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment.

Fineberg NA, Apergis-Schoute AM, Vaghi MM, Banca P, Gillan CM, Voon V, Chamberlain SR, Cinosi E, Reid J, Shahper S, Bullmore ET, Sahakian BJ, Robbins TW.

Int J Neuropsychopharmacol. 2018 Jan 1;21(1):42-58. doi: 10.1093/ijnp/pyx088. Review.

33.

Cognitive Training Using a Novel Memory Game on an iPad in Patients with Amnestic Mild Cognitive Impairment (aMCI).

Savulich G, Piercy T, Fox C, Suckling J, Rowe JB, O'Brien JT, Sahakian BJ.

Int J Neuropsychopharmacol. 2017 Aug 1;20(8):624-633. doi: 10.1093/ijnp/pyx040.

34.

Diffusion tensor imaging profiles reveal specific neural tract distortion in normal pressure hydrocephalus.

Keong NC, Pena A, Price SJ, Czosnyka M, Czosnyka Z, DeVito EE, Housden CR, Sahakian BJ, Pickard JD.

PLoS One. 2017 Aug 17;12(8):e0181624. doi: 10.1371/journal.pone.0181624. eCollection 2017.

35.

PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.

Koychev I, Gunn RN, Firouzian A, Lawson J, Zamboni G, Ridha B, Sahakian BJ, Rowe JB, Thomas A, Rochester L, Ffytche D, Howard R, Zetterberg H, MacKay C, Lovestone S; Deep and Frequent Phenotyping study team (.

J Alzheimers Dis. 2017;60(1):283-293. doi: 10.3233/JAD-170129. Erratum in: J Alzheimers Dis. 2018;63(1):407.

36.

Adolescent Major Depressive Disorder: Neuroimaging Evidence of Sex Difference during an Affective Go/No-Go Task.

Chuang JY, Hagan CC, Murray GK, Graham JME, Ooi C, Tait R, Holt RJ, Elliott R, van Nieuwenhuizen AO, Bullmore ET, Lennox BR, Sahakian BJ, Goodyer IM, Suckling J.

Front Psychiatry. 2017 Jul 11;8:119. doi: 10.3389/fpsyt.2017.00119. eCollection 2017.

37.

Neural correlates of visual memory in patients with diffuse axonal injury.

Lauer J, Moreno-López L, Manktelow A, Carroll EL, Outtrim JG, Coles JP, Newcombe VF, Sahakian BJ, Menon DK, Stamatakis EA.

Brain Inj. 2017;31(11):1513-1520. doi: 10.1080/02699052.2017.1341998. Epub 2017 Jul 14.

PMID:
28707953
38.

Cooperative Behavior in the Ultimatum Game and Prisoner's Dilemma Depends on Players' Contributions.

Bland AR, Roiser JP, Mehta MA, Schei T, Sahakian BJ, Robbins TW, Elliott R.

Front Psychol. 2017 Jun 16;8:1017. doi: 10.3389/fpsyg.2017.01017. eCollection 2017.

39.

Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.

Passamonti L, Luijten M, Ziauddeen H, Coyle-Gilchrist ITS, Rittman T, Brain SAE, Regenthal R, Franken IHA, Sahakian BJ, Bullmore ET, Robbins TW, Ersche KD.

Psychopharmacology (Berl). 2017 Aug;234(15):2289-2297. doi: 10.1007/s00213-017-4643-4. Epub 2017 May 27.

40.

Advanced magnetic resonance imaging and neuropsychological assessment for detecting brain injury in a prospective cohort of university amateur boxers.

Hart MG, Housden CR, Suckling J, Tait R, Young A, Müller U, Newcombe VFJ, Jalloh I, Pearson B, Cross J, Trivedi RA, Pickard JD, Sahakian BJ, Hutchinson PJ.

Neuroimage Clin. 2017 Apr 26;15:194-199. doi: 10.1016/j.nicl.2017.04.026. eCollection 2017.

41.

Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.

d'Angelo LC, Savulich G, Sahakian BJ.

Br J Pharmacol. 2017 Oct;174(19):3257-3267. doi: 10.1111/bph.13813. Epub 2017 May 12. Review.

42.

Working Memory after Traumatic Brain Injury: The Neural Basis of Improved Performance with Methylphenidate.

Manktelow AE, Menon DK, Sahakian BJ, Stamatakis EA.

Front Behav Neurosci. 2017 Apr 5;11:58. doi: 10.3389/fnbeh.2017.00058. eCollection 2017.

43.

Modafinil Improves Episodic Memory and Working Memory Cognition in Patients With Remitted Depression: A Double-Blind, Randomized, Placebo-Controlled Study.

Kaser M, Deakin JB, Michael A, Zapata C, Bansal R, Ryan D, Cormack F, Rowe JB, Sahakian BJ.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Mar;2(2):115-122. doi: 10.1016/j.bpsc.2016.11.009.

44.

Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery.

Savulich G, Riccelli R, Passamonti L, Correia M, Deakin JF, Elliott R, Flechais RS, Lingford-Hughes AR, McGonigle J, Murphy A, Nutt DJ, Orban C, Paterson LM, Reed LJ, Smith DG, Suckling J, Tait R, Taylor EM, Sahakian BJ, Robbins TW, Ersche KD.

Transl Psychiatry. 2017 Mar 7;7(3):e1054. doi: 10.1038/tp.2017.34.

45.

Neural basis of impaired safety signaling in Obsessive Compulsive Disorder.

Apergis-Schoute AM, Gillan CM, Fineberg NA, Fernandez-Egea E, Sahakian BJ, Robbins TW.

Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3216-3221. doi: 10.1073/pnas.1609194114. Epub 2017 Mar 6.

46.

Cognitive Behavioral Therapy Lowers Elevated Functional Connectivity in Depressed Adolescents.

Chattopadhyay S, Tait R, Simas T, van Nieuwenhuizen A, Hagan CC, Holt RJ, Graham J, Sahakian BJ, Wilkinson PO, Goodyer IM, Suckling J.

EBioMedicine. 2017 Mar;17:216-222. doi: 10.1016/j.ebiom.2017.02.010. Epub 2017 Feb 16.

47.

Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals.

Morris LS, Baek K, Tait R, Elliott R, Ersche KD, Flechais R, McGonigle J, Murphy A, Nestor LJ, Orban C, Passetti F, Paterson LM, Rabiner I, Reed L, Smith D, Suckling J, Taylor EM, Bullmore ET, Lingford-Hughes AR, Deakin B, Nutt DJ, Sahakian BJ, Robbins TW, Voon V; ICCAM Consortium.

Addict Biol. 2018 Jan;23(1):425-436. doi: 10.1111/adb.12503. Epub 2017 Feb 28.

48.

Neuroscience-based Nomenclature: improving clinical and scientific terminology in research and clinical psychopharmacology.

Brühl AB, Sahakian BJ.

Psychol Med. 2017 Jun;47(8):1339-1341. doi: 10.1017/S0033291716003603. Epub 2017 Jan 18. No abstract available.

PMID:
28095940
49.

A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.

Cha DS, Best MW, Bowie CR, Gallaugher LA, Woldeyohannes HO, Soczynska JK, Lewis G, MacQueen G, Sahakian BJ, Kennedy SH, Lui JP, Mansur RB, McIntyre RS.

J Affect Disord. 2017 Mar 1;210:57-65. doi: 10.1016/j.jad.2016.12.006. Epub 2016 Dec 18.

PMID:
28013123
50.

Anything goes? Regulation of the neural processes underlying response inhibition in TBI patients.

Moreno-López L, Manktelow AE, Sahakian BJ, Menon DK, Stamatakis EA.

Eur Neuropsychopharmacol. 2017 Feb;27(2):159-169. doi: 10.1016/j.euroneuro.2016.12.002. Epub 2016 Dec 21.

PMID:
28012706

Supplemental Content

Loading ...
Support Center